The LDOC1L Polyclonal Antibody (PAC021879) is a valuable tool for researchers studying LDOC1L, a protein involved in cell signaling pathways and gene regulation. This antibody, generated in rabbits, is highly specific to human samples and is validated for use in Western blotting applications. By binding to the LDOC1L protein, this antibody enables accurate detection and analysis in various cell types, making it an ideal choice for studies in molecular biology and cancer research.
LDOC1L, also known as Leucine zipper down-regulated in cancer 1-like protein, is a key player in regulating cellular processes such as cell growth and proliferation. Its involvement in cancer development and progression makes it a promising target for therapeutic interventions and biomarker discovery. Researchers investigating the role of LDOC1L in cancer biology and potential treatment strategies will benefit from using this reliable antibody to advance their studies.
Antibody Name:
LDOC1L Antibody (PACO21879)
Antibody SKU:
PACO21879
Size:
100ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:3000
Species Reactivity:
Human, Mouse
Immunogen:
Synthesized peptide derived from internal of human LDOCL.
Form:
Liquid
Storage Buffer:
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen Ota T., Nat. Genet. 36:40-45(2004).
Clonality:
Polyclonal
Conjugate:
Non-conjugated
Western blot analysis of extracts from COLO205 cells, using LDOCL antibody.
Synonyms:
Protein LDOC1L; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon-derived protein 6; LDOC1L; MAR6
